tiprankstipranks
Trending News
More News >
Calian Group Ltd. (TSE:CGY)
TSX:CGY
Canadian Market
Advertisement

Calian Group (CGY) AI Stock Analysis

Compare
136 Followers

Top Page

TSE:CGY

Calian Group

(TSX:CGY)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 4o)
Rating:61Neutral
Price Target:
C$53.00
▼(-2.05% Downside)
Calian Group's strong revenue growth and cash flow generation are significant positives, supported by a robust backlog and strategic investments in the defense sector. However, declining profitability, increased leverage, and challenges in the ITCS segment weigh on the overall score. The negative P/E ratio and neutral technical indicators further temper the outlook.
Positive Factors
Revenue Growth
The robust top-line expansion indicates strong market demand and effective business strategies, supporting long-term growth potential.
Defense Sector Expansion
The defense sector's significant growth enhances Calian's market position and revenue stability, leveraging increased demand in Canada and Europe.
Backlog Growth
A growing backlog indicates strong future revenue streams and business sustainability, providing a buffer against market fluctuations.
Negative Factors
Profitability Decline
Declining profitability suggests challenges in cost management, which could impact long-term financial health and operational efficiency.
ITCS Segment Challenges
The downturn in the ITCS segment indicates potential structural issues, affecting overall company performance and necessitating strategic adjustments.
Increased Leverage
Higher leverage can strain financial flexibility and increase risk, potentially impacting the company's ability to invest in growth opportunities.

Calian Group (CGY) vs. iShares MSCI Canada ETF (EWC)

Calian Group Business Overview & Revenue Model

Company DescriptionCalian Group Ltd. (CGY) is a Canadian diversified company that provides a wide range of services in multiple sectors, including healthcare, information technology, engineering, and training. The company operates through several divisions, delivering innovative solutions to government and commercial clients. Calian's core products and services include healthcare staffing solutions, IT and cybersecurity services, engineering and technical support, and training programs, addressing the needs of various industries and enhancing operational efficiencies.
How the Company Makes MoneyCalian generates revenue through a diverse array of streams. Primarily, the company earns income from its professional services divisions, which include healthcare staffing and IT support services. The healthcare division provides personnel to hospitals and clinics, while the IT sector offers cybersecurity and technology solutions to both public and private entities. Additionally, Calian's engineering and training services contribute significantly to its revenue, with contracts often awarded by government agencies and large corporations. Strategic partnerships with both public sector clients and private industry players also enhance its market reach and profitability. The company's ability to secure long-term contracts and maintain a robust pipeline of projects is crucial for sustaining its earnings.

Calian Group Earnings Call Summary

Earnings Call Date:Nov 26, 2025
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Feb 12, 2026
Earnings Call Sentiment Positive
Calian Group's earnings call highlighted record revenue and growth, driven by strong performance in the defense sector and strategic acquisitions. However, challenges in the ITCS segment and uncertainties regarding defense investment timing were noted. Despite these challenges, the overall outlook remains positive with expectations of double-digit growth in FY 2026.
Q4-2025 Updates
Positive Updates
Record Revenue and Growth
Calian Group delivered record results with the highest revenue quarter in its 43-year history and the second highest adjusted EBITDA. Revenues increased by 12% to $203 million in Q4, with a return to positive organic growth. The fiscal year 2025 revenues were up 4% to $774 million, a new record for the company.
Defense Solutions Expansion
Defense Solutions continues to lead with double-digit growth and now represents 50% of consolidated revenues. Revenues grew 17% year-over-year, driven by increased demand across Canada, the U.K., and Europe. Significant contract wins include agreements with NATO and Allied countries, and a $250 million expansion to the health services contract with Canadian Armed Forces.
Global Presence and Strategic Acquisitions
48% of Q4 revenues were generated outside Canada, marking the highest quarter in terms of international revenue. Strategic acquisitions like AMS and InField Scientific have strengthened Calian's capabilities, particularly in defense and health care.
Strong Cash Flow and Shareholder Returns
Calian generated $45 million in cash flow from operations and maintained working capital efficiency below 10%. The company returned value to shareholders with $13 million in dividends and $26 million in share buybacks, representing approximately 5% of shares outstanding.
Positive Outlook and Strategic Direction
For fiscal year 2026, Calian expects double-digit growth in both revenue and adjusted EBITDA. The company plans to focus on high-growth vertical markets like defense and space, streamline operations, and invest with discipline.
Negative Updates
ITCS Segment Underperformance
The ITCS segment saw revenues decline by 4%, impacting the overall adjusted EBITDA margin, which stood at 11.9%, down from 13.1% last year. Material actions were taken in Q4 to restore performance, but their impact was limited this period.
Challenges in Organic Growth
Organic growth for the fiscal year was negative 2%, primarily due to defense cuts in the first half, delays in major space programs, and uncertainty surrounding tariffs at the beginning of the year.
Uncertain Timing of Defense Investments
While the Canadian federal budget is seen as positive for Calian, the timing of contract awards remains uncertain, which could impact future revenue and growth projections.
Company Guidance
During the Calian Group's Fourth Quarter 2025 Earnings Conference Call, several key metrics and guidance for future growth were discussed. The company reported its highest revenue quarter in its 43-year history, with Q4 revenues increasing by 12% to $203 million. The Defense Solutions segment was highlighted as a major growth driver, achieving double-digit growth and representing 50% of consolidated revenues. Year-end signings totaled $1 billion, a 48% increase over the previous year. The backlog reached $1.4 billion, with $1 billion attributed to the defense sector. For fiscal year 2026, Calian anticipates double-digit revenue growth, driven by strategic acquisitions and organic growth, with an aim to expand adjusted EBITDA as the company focuses on high-growth verticals, particularly in defense and space. The company's financial flexibility is supported by a $350 million revolving credit facility, enabling continued investment in M&A and strategic initiatives.

Calian Group Financial Statement Overview

Summary
Calian Group demonstrates strong revenue growth and cash flow generation, which are positive indicators of business expansion and operational efficiency. However, declining profitability margins and increased leverage pose potential risks. The company needs to focus on improving cost management and profitability to enhance overall financial health.
Income Statement
65
Positive
Calian Group shows a strong revenue growth trajectory with a TTM growth rate of 96.9%, indicating robust top-line expansion. However, profitability metrics such as net profit margin and EBIT margin have declined significantly, with a negative net profit margin in the TTM period. This suggests challenges in cost management or increased expenses impacting the bottom line.
Balance Sheet
70
Positive
The company's debt-to-equity ratio has increased over time, indicating higher leverage, but it remains at a manageable level. The equity ratio is stable, reflecting a solid capital structure. However, the negative return on equity in the TTM period is concerning, suggesting inefficiencies in generating returns on shareholder investments.
Cash Flow
75
Positive
Calian Group's cash flow metrics are strong, with a significant increase in free cash flow growth and a healthy free cash flow to net income ratio. The operating cash flow to net income ratio is positive, indicating good cash generation relative to reported earnings, despite the net income loss in the TTM period.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue752.10M746.61M658.58M582.17M518.40M432.32M
Gross Profit254.22M254.01M204.21M169.23M126.74M89.16M
EBITDA50.42M70.78M59.27M56.06M37.59M38.79M
Net Income-659.00K11.18M18.89M13.60M11.15M20.36M
Balance Sheet
Total Assets723.59M707.92M585.72M547.16M457.97M331.05M
Cash, Cash Equivalents and Short-Term Investments56.83M51.79M33.73M42.65M78.61M24.23M
Total Debt184.68M129.19M74.76M26.54M17.48M19.59M
Total Liabilities422.33M381.17M257.35M241.98M165.61M130.65M
Stockholders Equity301.25M326.75M328.37M305.19M292.36M200.41M
Cash Flow
Free Cash Flow48.67M75.42M48.34M35.82M38.69M-8.55M
Operating Cash Flow58.45M87.22M56.77M43.14M46.54M-2.75M
Investing Cash Flow-48.86M-99.67M-79.62M-72.89M-56.61M-35.19M
Financing Cash Flow2.43M30.50M13.94M-6.21M64.44M45.04M

Calian Group Technical Analysis

Technical Analysis Sentiment
Positive
Last Price54.11
Price Trends
50DMA
50.46
Positive
100DMA
50.43
Positive
200DMA
47.09
Positive
Market Momentum
MACD
0.09
Negative
RSI
62.16
Neutral
STOCH
86.86
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CGY, the sentiment is Positive. The current price of 54.11 is above the 20-day moving average (MA) of 50.19, above the 50-day MA of 50.46, and above the 200-day MA of 47.09, indicating a bullish trend. The MACD of 0.09 indicates Negative momentum. The RSI at 62.16 is Neutral, neither overbought nor oversold. The STOCH value of 86.86 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:CGY.

Calian Group Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
C$640.22M18.6414.38%3.02%-0.73%221.74%
69
Neutral
C$470.40M20.888.30%3.43%26.29%-6.47%
68
Neutral
C$1.70B9.719.36%9.25%-2.90%57.43%
67
Neutral
C$700.56M20.018.55%-2.83%179.03%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
61
Neutral
C$575.68M-934.076.36%2.07%3.69%92.38%
56
Neutral
C$73.01M10.6526.87%4.26%-7.01%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CGY
Calian Group
54.11
4.88
9.91%
TSE:DCM
Data Commun Management
1.76
0.06
3.53%
TSE:GDI
GDI Integrated
28.10
-7.71
-21.53%
TSE:DXT
Dexterra Group
11.99
4.91
69.35%
TSE:KBL
K-Bro Linen
34.97
-2.49
-6.65%
TSE:TCL.B
Transcontinental Inc. Class B
20.47
6.02
41.66%

Calian Group Corporate Events

Business Operations and Strategy
Calian Group Enhances Ottawa Airport’s Cybersecurity with New SOC Contract
Positive
Oct 15, 2025

Calian Group Ltd. has secured a three-year contract with the Ottawa International Airport Authority to implement and manage a cyber-focused Security Operations Centre (SOC). This initiative is part of the airport’s strategy to enhance its cybersecurity capabilities, reflecting a forward-thinking approach to protecting both physical and virtual environments. The partnership builds on a successful IT modernization project and represents a shift towards leveraging advanced systems to support future growth. Calian’s tailored, expert-driven SOC solutions are designed to provide seamless protection, enabling clients to focus on their core operations with confidence in their security posture.

The most recent analyst rating on (TSE:CGY) stock is a Hold with a C$56.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
Calian Group Announces CEO Transition Amidst Record Growth
Positive
Oct 7, 2025

Calian Group Ltd. announced the retirement of Kevin Ford as CEO after a decade of record growth, with Patrick Houston set to succeed him on January 1, 2026. Under Ford’s leadership, Calian expanded into new markets and diversified its capabilities, establishing itself as a global provider of mission-critical solutions. Houston, who has been instrumental in driving growth through strategic acquisitions and development, aims to continue this momentum by focusing on strategic plans that enhance shareholder value and position Calian for sustained growth.

The most recent analyst rating on (TSE:CGY) stock is a Hold with a C$56.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Business Operations and StrategyM&A Transactions
Calian Group Expands Defence Capabilities with InField Scientific Acquisition
Positive
Oct 2, 2025

Calian Group Ltd. has acquired InField Scientific Inc., a Quebec-based engineering company known for its expertise in electromagnetic environmental effects (E3). This acquisition enhances Calian’s defence portfolio, enabling it to offer comprehensive electromagnetic solutions and expand into new markets. The collaboration with InField Scientific will support projects like Canada’s next-generation destroyers, strengthening relationships with key partners such as Lockheed Martin and the Royal Canadian Navy. The acquisition is expected to generate operational synergies and broaden service offerings, positioning Calian for future opportunities in defence markets.

The most recent analyst rating on (TSE:CGY) stock is a Hold with a C$56.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
Calian Group Expands Debt Facility to Support Growth Strategy
Positive
Sep 29, 2025

Calian Group Ltd. has announced the renewal and expansion of its debt agreement, securing a CDN$200 million facility with a syndicate led by Royal Bank of Canada and including other major financial institutions. The new three-year revolving credit facility totals $350 million, marking a 37% increase over the previous facility, and includes an uncommitted accordion feature for additional financial flexibility. This agreement reflects confidence in Calian’s business fundamentals and long-term strategy, positioning the company to pursue consistent growth and value creation in its core markets.

The most recent analyst rating on (TSE:CGY) stock is a Hold with a C$56.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Business Operations and StrategyProduct-Related Announcements
Calian Group Launches Canada’s First Defence Innovation Orchestrator
Positive
Sep 23, 2025

Calian Group Ltd. has launched Calian Ventures, Canada’s first defence innovation orchestrator, aimed at scaling small to mid-sized enterprises (SMEs) in the defence sector. This initiative will help SMEs test, validate, and scale their technologies into operational capabilities for the Canadian Armed Forces and allied markets, addressing a critical gap in Canada’s defence industrial ecosystem and supporting the country’s surge in defence spending.

The most recent analyst rating on (TSE:CGY) stock is a Hold with a C$56.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Calian Group’s Earnings Call: Growth Amid Challenges
Sep 1, 2025

Calian Group Ltd.’s recent earnings call presented a nuanced picture of the company’s current standing, highlighting both promising growth areas and notable challenges. The sentiment conveyed was a blend of optimism and caution, with significant achievements in the defense and international sectors counterbalanced by struggles within the ITCS segment. Despite these hurdles, the company remains optimistic about future growth, supported by a strong backlog and strategic initiatives.

Business Operations and StrategyStock Buyback
Calian Group Renews Share Repurchase Program to Enhance Shareholder Value
Positive
Aug 28, 2025

Calian Group Ltd. announced the renewal of its normal course issuer bid (NCIB), allowing the company to repurchase up to 796,283 of its common shares over a 12-month period. This move reflects the company’s belief that its current share price does not fully capture its intrinsic value and long-term potential. With a $1.5 billion backlog and over a decade of record revenue, Calian aims to enhance shareholder value and maintain flexibility in its capital management strategy.

The most recent analyst rating on (TSE:CGY) stock is a Hold with a C$51.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
Calian Group Reaffirms Strategic Direction Amidst Stakeholder Scrutiny
Neutral
Aug 27, 2025

Calian Group Ltd. has reaffirmed its strategic direction and commitment to long-term shareholder value amidst recent scrutiny from Plantro Ltd. The company is enhancing its operations by consolidating key business units, refreshing its Board of Directors, and exploring options for non-core assets, aiming to capitalize on market opportunities and deliver sustained value to shareholders.

The most recent analyst rating on (TSE:CGY) stock is a Hold with a C$51.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Calian Group Reports Strong Q3 Growth in Defense Sector
Positive
Aug 13, 2025

Calian Group Ltd. reported a 12% increase in defense solutions revenue for the third quarter, driven by strong momentum in Europe and the U.K. and growing investments in Canada. The company announced a $250 million increase in its health contract with the Department of National Defence, contributing to a robust 9% revenue growth excluding the ITCS segment, which faced demand challenges. The quarter also saw new contract signings totaling $642 million, bringing the backlog to a record $1.5 billion. Despite a decline in adjusted EBITDA due to lower ITCS profitability, Calian remains confident in its growth trajectory, supported by strategic acquisitions and a strong cash flow position.

The most recent analyst rating on (TSE:CGY) stock is a Buy with a C$75.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 02, 2025